These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Evaluation of the immunotoxicity of sulfanilamide, anti-inflammatory and antihistaminic preparations]. Shaĭdrov VV; Ionov ID Farmakol Toksikol; 1988; 51(3):82-4. PubMed ID: 2900777 [TBL] [Abstract][Full Text] [Related]
43. [Pharmacokinetic studies On delmethacin and indomethacin in the rat]. Rimbau V; Forn J Arch Farmacol Toxicol; 1982 Dec; 8(3):201-4. PubMed ID: 6765900 [No Abstract] [Full Text] [Related]
44. Studies on an anti-inflammatory agent. III. Pharmacological investigations of a new non-steroidal anti-inflammatory agent: 2-oxo-3-[4-(1-oxo-2-isoindolinyl)-phenyl]-butanamide (GP 650). Fukawa K; Kanezuka T; Ohba S; Kawano O; Hibi M; Misaki N; Sawabe T Arzneimittelforschung; 1982; 32(3):225-30. PubMed ID: 6979341 [TBL] [Abstract][Full Text] [Related]
45. Rapid induction of a tolerance to the anti-inflammatory action of aminopyrine. Jaques R Helv Physiol Pharmacol Acta; 1965; 23(3):307-10. PubMed ID: 5860613 [No Abstract] [Full Text] [Related]
51. [Chronic toxicity of bufexamac in the rat and monkey]. Lambelin G; Roba J; Roncucci R Boll Chim Farm; 1974 Aug; 113(8):437-54. PubMed ID: 4215440 [No Abstract] [Full Text] [Related]
52. [Toxicity and biological activity of sulfolane derivatives]. Lazareva DN; Davydova VA; Kamalova EG; Tolstikov GA; Novitskaia NN Farmakol Toksikol; 1981; 44(4):482-4. PubMed ID: 7286213 [No Abstract] [Full Text] [Related]
53. [On clinical evaluation of the effect of azapropazon, a new anti-inflammatory agent, in diseases of the rheumatic group]. Beckschäfer W Arzneimittelforschung; 1969 Jan; 19(1):52-3. PubMed ID: 4182977 [No Abstract] [Full Text] [Related]
54. [Toxicologic studies on the effect of azapropazone on reproduction in the rat]. Adrian RW Arzneimittelforschung; 1973 May; 23(5):658-60. PubMed ID: 4740206 [No Abstract] [Full Text] [Related]
55. Survey of the biological properties of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370), a novel agent in the class of anti-inflammatory drugs. Bianchi C Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:249-5. PubMed ID: 5067202 [No Abstract] [Full Text] [Related]
56. Pharmacological aspects of pyrazoline derivatives from 2-hydroxy-butenolides. Chanh PH; Sokan I; Couquelet JM; Couquelet JD; Thibault A; Cros J Arzneimittelforschung; 1976; 26(11):2050-2. PubMed ID: 1037245 [TBL] [Abstract][Full Text] [Related]
57. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis. Mollinedo F; Gajate C; Morales AI; del Canto-Jañez E; Justies N; Collía F; Rivas JV; Modolell M; Iglesias A J Pharmacol Exp Ther; 2009 May; 329(2):439-49. PubMed ID: 19244550 [TBL] [Abstract][Full Text] [Related]
58. Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals. Perianayagam JB; Sharma SK; Pillai KK J Ethnopharmacol; 2006 Apr; 104(3):410-4. PubMed ID: 16303271 [TBL] [Abstract][Full Text] [Related]
59. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones. Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187 [No Abstract] [Full Text] [Related]